Corrigendum for “Potent nanoreactor-mediated ferroptosis-based strategy for the reversal of cancer chemoresistance to Sorafenib” [Acta Biomaterialia, 2023, 159, 237-246](S1742706123000569)(10.1016/j.actbio.2023.01.053)

Xiaorui Wang, Lei Zhao, Chenxi Wang, Leichen Wang, Haisi Wu, Xuejiao Song, Wenjun Wang, Huae Xu, Xiaochen Dong

Research output: Contribution to journal › Comment/debate

Fingerprint

Dive into the research topics of 'Corrigendum for “Potent nanoreactor-mediated ferroptosis-based strategy for the reversal of cancer chemoresistance to Sorafenib” [Acta Biomaterialia, 2023, 159, 237-246](S1742706123000569)(10.1016/j.actbio.2023.01.053)'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Nursing and Health Professions

Neuroscience

Engineering